Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Chunxin, Xiao"'
Publikováno v:
Data in Brief, Vol 15, Iss , Pp 612-614 (2017)
The data presented in this article are related to the research article entitled âIsobarictags for relative and absolute quantitation (iTRAQ) -based proteomics for the investigation of the effect of HuganQingzhi on non-alcoholic fatty liver disease i
Externí odkaz:
https://doaj.org/article/e0a8b60e09a4461a9f64b87edb4aada2
Publikováno v:
Data in Brief, Vol 15, Iss, Pp 612-614 (2017)
Data in Brief
Data in Brief
The data presented in this article are related to the research article entitled “Isobarictags for relative and absolute quantitation (iTRAQ) -based proteomics for the investigation of the effect of HuganQingzhi on non-alcoholic fatty liver disease
Publikováno v:
Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 38(11)
OBJECTIVE: To investigate the effects of sera from rats fed with Huganqingzhi tablets (HGT) on endoplasmic reticulum (ER) stress in a steatotic hepatocyte model of free fatty acids (FFAs)-induced nonalcoholic fatty liver disease (NAFLD) and explore t
Publikováno v:
Frontiers in Pharmacology
In previous research, Hugan Qingzhi, a traditional Chinese medicine, was shown to have protective effects against hepatic steatosis. However, its activity against nonalcoholic fatty liver disease (NAFLD) and the mechanisms by which it exerts its effe
Publikováno v:
Journal of ethnopharmacology. 212
Ethnopharmacological relevance Hugan Qingzhi tablet (HQT), a traditional Chinese medicine formula has been adopted for preventing and treating nonalcoholic fatty liver disease (NAFLD). Aim In order to explore the anti-NAFLD mechanisms of HQT, iTRAQ-b
Publikováno v:
Pharmacognosy Magazine. 14:597
Background: Alismatis Rhizoma (AR) is a traditional Chinese medicine that is frequently used for the treatment of hyperlipidemia, hypertension, diabetes, and chronic kidney failure. Active alisols contribute to the beneficial effects of AR and AR pro
Publikováno v:
Frontiers in Pharmacology; 2/28/2017, Vol. 8, p1-14, 14p